NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status
- Citation:
- J Thorac Oncol vol 9 (8) 1146-1153
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 424
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10 CA035267, U10 CA035269, CA-37404, CA-35090, U10 CA037404, U10 CA180821, U10 CA063848, CA-35103, CA-25224, CA-35113, UG1 CA189823, U10 CA035113, CA-63848, U10 CA035415, U10 CA063849, U10 CA180882, CA-35415, CA-35269, U10 CA025224, U10 CA035090, CA-35267, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Grace K. Dy Julian R. Molina Yingwei Qi Rafat Ansari Sachdev Thomas Helen J. Ross Gamini Soori Daniel Anderson Marie Christine Aubry Jeffrey Meyers Araba A. Adjei Sumithra Mandrekar Alex A. Adjei
- Networks:
- Study
- NCCTG-N0821
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Non-small cell lung cancer, Elderly, Nonsquamous histology, Bevacizumab, Survival